UCB SA header image

UCB SA

UCB

Equity

ISIN BE0003739530 / Valor 986410

Euronext - Euronext Brussels (2026-10-06)

EUR 202.30+0.70%

UCB SA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

UCB SA is a global biopharmaceutical company focused on the research, development, and commercialization of innovative therapies for severe diseases, particularly in the areas of neurology and immunology. Through its investment division, UCB Ventures, the company supports pioneering startups and technologies that aim to improve the lives of individuals affected by challenging health conditions. By leveraging its expertise and resources, UCB SA strives to address unmet medical needs and deliver impactful medical solutions to patients worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-20.1%1Y

158%3Y

106%5Y

Performance

37.0%1Y

32.6%3Y

30.0%5Y

Volatility

43132 M

Market cap (USD)

213,583

Daily traded volume (Shares)

192.15 / 187.65

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

IQVIA Holdings Inc

IQVIA Holdings Inc Valor: 39103858

Annual Return

-50%0%+50%

Risk level

110

-2.30%USD 259.98

Arvinas Inc

Arvinas Inc Valor: 43526042

Annual Return

-50%0%+50%

Risk level

110

-2.01%USD 7.31

AstraZeneca PLC

AstraZeneca PLC Valor: 982352

Annual Return

-50%0%+50%

Risk level

110

1.65%GBP 119.58

Smith & Nephew PLC

Smith & Nephew PLC Valor: 1103058

Annual Return

-50%0%+50%

Risk level

110

0.70%GBP 10.12

Envista Holdings Corporation

Envista Holdings Corporation Valor: 49153522

Annual Return

-50%0%+50%

Risk level

110

-0.30%USD 23.27

Humana Inc

Humana Inc Valor: 940174

Annual Return

-50%0%+50%

Risk level

110

0.05%USD 404.27

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC Valor: 2324471

Annual Return

-50%0%+50%

Risk level

110

2.60%GBP 16.20

Indivior PLC

Indivior PLC Valor: 121550831

Annual Return

-50%0%+50%

Risk level

110

-0.67%GBP 27.04

Beximco Pharmaceuticals Ltd

Beximco Pharmaceuticals Ltd Valor: 2318407

Annual Return

-50%0%+50%

Risk level

110

0.00%GBP 0.54

Pharma Mar SA

Pharma Mar SA Valor: 56130572

Annual Return

-50%0%+50%

Risk level

110

0.93%EUR 70.30

SIX

FactSet

Clearbit

Logos provided by Clearbit